BME •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/29/2026 09:50
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBME
Market Capitalization6,017.68 mln
Float419 mln
Earnings Date07/29/2026
EPS
0.61
Moderate
P / E
17.21
Moderately valued
1-Year Forecast
14.40
Strong upside
Relative Strength
97
/ 100
Top performer
Debt / Equity
1.77
High leverage
Pre-Tax Margin
16%
Healthy margin
Business Description
Founded in 1909 and based in Barcelona, Spain, Grifols is a global healthcare company best known for turning human plasma into medicines that treat a wide range of serious conditions, from immune disorders to neurological diseases. The company also develops diagnostic tools and testing services used by hospitals and life-science researchers around the world. Beyond plasma, Grifols supplies hospitals with intravenous fluids, clinical nutrition products, and automated pharmacy systems, while also providing contract manufacturing and development services to other pharmaceutical and biotech companies.
